Perioperative Aspirin Management: Evidence-Based Approach
Direct Answer
For low-risk surgeries like cataract extraction, continue aspirin 81 mg throughout the perioperative period without interruption. For high-bleeding-risk surgeries including spinal fusion, stop aspirin 5-7 days before surgery and resume within 24 hours postoperatively when hemostasis is secure. For neurosurgical procedures, stop aspirin 5-7 days preoperatively in high-thrombotic-risk patients only after careful risk-benefit assessment, but strongly consider continuation in patients with recent coronary stents or high cardiovascular risk.
Low-Risk Surgery (Cataract Extraction)
Continue aspirin without interruption 1. The 2022 CHEST guidelines support aspirin continuation when cardiac event risk outweighs bleeding risk 2. A 2025 meta-analysis of 65,196 cataract surgery patients demonstrated that aspirin continuation increases only subconjunctival hemorrhage risk (RR: 1.74), but does not increase sight-threatening complications including hyphema, retrobulbar hemorrhage, vitreous hemorrhage, or visual acuity changes 1.
Key Clinical Points:
- Subconjunctival hemorrhage is cosmetically concerning but clinically benign
- No increased risk of vision-threatening bleeding
- Thrombotic risk from aspirin discontinuation far exceeds minimal bleeding risk in this population
High-Bleeding-Risk Surgery (Spinal Fusion)
Stop aspirin 5-7 days before surgery 2, 3. The 2022 CHEST guidelines specifically note that high-bleed-risk procedures (intracranial, spinal) may require ≤7 days interruption 2.
Evidence Supporting This Approach:
A 2011 study demonstrated that even when aspirin was stopped 7 days preoperatively, postoperative blood drainage was significantly higher (864.4 cc vs 458.4 cc, p<0.001) with greater transfusion requirements (p=0.03) 4. However, a 2017 meta-analysis found no significant differences in perioperative blood loss between continuation and discontinuation groups 5, though this included only three small studies.
Timing Specifics:
- Discontinuation: Stop 5-7 days preoperatively (aspirin's platelet effect lasts 7-10 days) 2
- Resumption: Restart within 24 hours postoperatively once surgical hemostasis is achieved 2
Critical Caveat:
The evidence is conflicting. While 4 shows increased postoperative drainage, 5 shows no significant difference. Given the potential for epidural hematoma and spinal cord compression in spinal surgery, err on the side of stopping aspirin despite mixed evidence.
Neurosurgical Procedures
Stop aspirin 5-7 days before surgery in most cases, but this requires individualized assessment based on thrombotic risk 3. A 2025 Delphi consensus of 42 international neurosurgical experts reached 87% agreement on 5-7 day preoperative cessation for high-bleeding-risk procedures 3.
Risk Stratification Algorithm:
High-Thrombotic-Risk Patients (recent MI, coronary stents, multiple cardiovascular risk factors):
- 97% of experts support continuing aspirin despite neurosurgical bleeding risk 3
- If aspirin must be stopped, minimize interruption duration
- Resume immediately postoperatively (within 24 hours) 2
Low-Thrombotic-Risk Patients:
- Stop aspirin 5-7 days preoperatively 3
- Only 65% expert agreement on continuation, reflecting ongoing controversy 3
- Resume within 24 hours postoperatively when hemostasis secure
Special Considerations:
The 2014 ACC/AHA guidelines emphasize that management decisions require consensus between surgeon, anesthesiologist, cardiologist, and patient 6. For patients with coronary stents:
- Continue aspirin if surgery is within 30 days of bare-metal stent or 12 months of drug-eluting stent 6
- Stopping aspirin in this timeframe poses Class III Harm recommendation 6
Evidence Nuances:
A 2024 narrative review challenges routine aspirin interruption in neurosurgery, noting that current ESC recommendations lack clinical evidence support 7. The 2025 Delphi study found 84% agreement that aspirin increases bleeding risk, but also near-universal agreement (97%) to continue in high-thrombotic-risk patients 3.
Common Pitfalls to Avoid
- Never stop aspirin in patients with recent coronary stents (≤30 days BMS, ≤12 months DES) without cardiology consultation 6
- Don't restart aspirin too early if surgical site bleeding persists—wait for secure hemostasis
- Don't assume 7-day interruption eliminates all bleeding risk—platelet turnover is 10% daily, so some aspirin effect persists 4
- Avoid routine platelet function testing—no consensus supports this practice 3
Summary Algorithm
Low-risk surgery (cataract) → Continue aspirin
High-bleeding-risk surgery (spinal fusion) → Stop 5-7 days pre-op, resume <24 hours post-op
Neurosurgery + high thrombotic risk → Continue aspirin (or minimize interruption)
Neurosurgery + low thrombotic risk → Stop 5-7 days pre-op, resume <24 hours post-op
Any surgery + recent coronary stent → Continue aspirin (Class I recommendation) 6